From psychiatrists to experts in telehealth, public health and primary care, a range of reactions from University of Michigan faculty to the recent federal proposal for mental health policy, and related issues.
Tag: Out-of-Pocket Costs
Annual Medicare spending could increase by $2 to $5 billion if Medicare expands coverage for dementia drug lecanemab
The anti-dementia medication lecanemab and its ancillary costs could add $2 billion to $5 billion in annual Medicare spending if the Centers for Medicare and Medicaid Services (CMS) revise their coverage decision. Currently, the medication is covered only for patients who are enrolled in clinical trials.
New neurology medication usage low due to high costs, similar effectiveness
While many new medications designed to treat neurologic diseases have hit the market, utilization by patients remains low due to high costs and similar effectiveness to existing drugs, a new study funded by the American Academy of Neurology finds.
Rush Health Partners with Oswego School District 308
Rush University System for Health entered into an agreement with Oswego Community Unit School District 308 to provide employees in the district’s health plan with discounted rates for medical services. The district plans to cover most out-of-pocket expenses (co-pays and deductibles) for care received at Rush.
Drug Coupons and Vouchers Cover Only a Sliver of Prescription Drugs
Use of vouchers and coupons offered by pharmaceutical companies to defray patients’ out-of-pocket drug costs is concentrated among a small number of drugs.